Selected research
Industry Research
Mometasone Industry Research Report 2026
Market perspective
The global Mometasone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mometasone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mometasone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mometasone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mometasone include Zhejiang Xianju Pharmaceutical, Shanghai Pharmaceuticals, Hubei Hengan Fulin Pharmaceutical, Bayer, Unilab Chemicals & Pharmaceuticals, Symbiotec Pharma, Perrigo Company, Hikma Pharmaceuticals and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mometasone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mometasone Market by Company
Zhejiang Xianju Pharmaceutical
Shanghai Pharmaceuticals
Hubei Hengan Fulin Pharmaceutical
Bayer
Unilab Chemicals & Pharmaceuticals
Symbiotec Pharma
Perrigo Company
Hikma Pharmaceuticals
Glenmark Pharmaceuticals
Aurisco Pharma
Mometasone Segment by Type
Over the counter
Prescription type
Mometasone Segment by Application
Retail pharmacies
Online pharmacies
Drug stores
Hospital pharmacies
Mometasone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mometasone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mometasone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mometasone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mometasone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mometasone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mometasone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Over the counter
- Prescription type
Applications
- Retail pharmacies
- Online pharmacies
- Drug stores
- Hospital pharmacies
Companies covered
- Zhejiang Xianju Pharmaceutical
- Shanghai Pharmaceuticals
- Hubei Hengan Fulin Pharmaceutical
- Bayer
- Unilab Chemicals & Pharmaceuticals
- Symbiotec Pharma
- Perrigo Company
- Hikma Pharmaceuticals
- Glenmark Pharmaceuticals
- Aurisco Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mometasone Market Size (2021-2032)
- 2.2.2 Global Mometasone Sales (2021-2032)
- 2.2.3 Global Mometasone Market Average Price (2021-2032)
- 2.3 Mometasone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Over the counter
- 2.3.3 Prescription type
- 2.4 Mometasone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail pharmacies
- 2.4.3 Online pharmacies
- 2.4.4 Drug stores
- 2.4.5 Hospital pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mometasone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mometasone Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Mometasone Revenue of Manufacturers (2021-2026)
- 3.4 Global Mometasone Average Price by Manufacturers (2021-2026)
- 3.5 Global Mometasone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mometasone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mometasone, Product Type & Application
- 3.8 Global Manufacturers of Mometasone, Established Date
- 3.9 Global Mometasone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Xianju Pharmaceutical
- 4.1.1 Zhejiang Xianju Pharmaceutical Company Information
- 4.1.2 Zhejiang Xianju Pharmaceutical Business Overview
- 4.1.3 Zhejiang Xianju Pharmaceutical Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Xianju Pharmaceutical Mometasone Product Portfolio
- 4.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 4.2 Shanghai Pharmaceuticals
- 4.2.1 Shanghai Pharmaceuticals Company Information
- 4.2.2 Shanghai Pharmaceuticals Business Overview
- 4.2.3 Shanghai Pharmaceuticals Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Pharmaceuticals Mometasone Product Portfolio
- 4.2.5 Shanghai Pharmaceuticals Recent Developments
- 4.3 Hubei Hengan Fulin Pharmaceutical
- 4.3.1 Hubei Hengan Fulin Pharmaceutical Company Information
- 4.3.2 Hubei Hengan Fulin Pharmaceutical Business Overview
- 4.3.3 Hubei Hengan Fulin Pharmaceutical Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hubei Hengan Fulin Pharmaceutical Mometasone Product Portfolio
- 4.3.5 Hubei Hengan Fulin Pharmaceutical Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Company Information
- 4.4.2 Bayer Business Overview
- 4.4.3 Bayer Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Mometasone Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 Unilab Chemicals & Pharmaceuticals
- 4.5.1 Unilab Chemicals & Pharmaceuticals Company Information
- 4.5.2 Unilab Chemicals & Pharmaceuticals Business Overview
- 4.5.3 Unilab Chemicals & Pharmaceuticals Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Unilab Chemicals & Pharmaceuticals Mometasone Product Portfolio
- 4.5.5 Unilab Chemicals & Pharmaceuticals Recent Developments
- 4.6 Symbiotec Pharma
- 4.6.1 Symbiotec Pharma Company Information
- 4.6.2 Symbiotec Pharma Business Overview
- 4.6.3 Symbiotec Pharma Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Symbiotec Pharma Mometasone Product Portfolio
- 4.6.5 Symbiotec Pharma Recent Developments
- 4.7 Perrigo Company
- 4.7.1 Perrigo Company Company Information
- 4.7.2 Perrigo Company Business Overview
- 4.7.3 Perrigo Company Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Perrigo Company Mometasone Product Portfolio
- 4.7.5 Perrigo Company Recent Developments
- 4.8 Hikma Pharmaceuticals
- 4.8.1 Hikma Pharmaceuticals Company Information
- 4.8.2 Hikma Pharmaceuticals Business Overview
- 4.8.3 Hikma Pharmaceuticals Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hikma Pharmaceuticals Mometasone Product Portfolio
- 4.8.5 Hikma Pharmaceuticals Recent Developments
- 4.9 Glenmark Pharmaceuticals
- 4.9.1 Glenmark Pharmaceuticals Company Information
- 4.9.2 Glenmark Pharmaceuticals Business Overview
- 4.9.3 Glenmark Pharmaceuticals Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Glenmark Pharmaceuticals Mometasone Product Portfolio
- 4.9.5 Glenmark Pharmaceuticals Recent Developments
- 4.10 Aurisco Pharma
- 4.10.1 Aurisco Pharma Company Information
- 4.10.2 Aurisco Pharma Business Overview
- 4.10.3 Aurisco Pharma Mometasone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aurisco Pharma Mometasone Product Portfolio
- 4.10.5 Aurisco Pharma Recent Developments
5 Global Mometasone Market Scenario by Region
- 5.1 Global Mometasone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mometasone Sales by Region: 2021-2032
- 5.2.1 Global Mometasone Sales by Region: 2021-2026
- 5.2.2 Global Mometasone Sales by Region: 2027-2032
- 5.3 Global Mometasone Revenue by Region: 2021-2032
- 5.3.1 Global Mometasone Revenue by Region: 2021-2026
- 5.3.2 Global Mometasone Revenue by Region: 2027-2032
- 5.4 North America Mometasone Market Facts & Figures by Country
- 5.4.1 North America Mometasone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mometasone Sales by Country (2021-2032)
- 5.4.3 North America Mometasone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Mometasone Market Facts & Figures by Country
- 5.5.1 Europe Mometasone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mometasone Sales by Country (2021-2032)
- 5.5.3 Europe Mometasone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Mometasone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mometasone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mometasone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mometasone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mometasone Market Facts & Figures by Country
- 5.7.1 South America Mometasone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mometasone Sales by Country (2021-2032)
- 5.7.3 South America Mometasone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Mometasone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mometasone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mometasone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mometasone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Mometasone Sales by Type (2021-2032)
- 6.1.1 Global Mometasone Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Mometasone Sales Market Share by Type (2021-2032)
- 6.2 Global Mometasone Revenue by Type (2021-2032)
- 6.2.1 Global Mometasone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mometasone Revenue Market Share by Type (2021-2032)
- 6.3 Global Mometasone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mometasone Sales by Application (2021-2032)
- 7.1.1 Global Mometasone Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Mometasone Sales Market Share by Application (2021-2032)
- 7.2 Global Mometasone Revenue by Application (2021-2032)
- 7.2.1 Global Mometasone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mometasone Revenue Market Share by Application (2021-2032)
- 7.3 Global Mometasone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mometasone Value Chain Analysis
- 8.1.1 Mometasone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mometasone Production Mode & Process
- 8.2 Mometasone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mometasone Distributors
- 8.2.3 Mometasone Customers
9 Global Mometasone Analyzing Market Dynamics
- 9.1 Mometasone Industry Trends
- 9.2 Mometasone Industry Drivers
- 9.3 Mometasone Industry Opportunities and Challenges
- 9.4 Mometasone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst